Merck KGaA has reached an agreement with SpringWorks on a $47-per-share takeover deal that values the US biotech at $3.9 ...

The NEJM has fired back a response to the Department of Justice (DoJ) asserting its "commitment to evidence-based ...

Anyone who purports to care about global health, about public health, should be speaking out against these actions, loudly ...

In its first-quarter results update, MSD – which is known as Merck & Co in the US and Canada – said it expects full-year ...

So far, SpringWorks – which was spun out of Pfizer in 2017 and has recently received FDA approval for a second therapy for a ...

Accurate KOL data is essential for ensuring that commercial and medical teams reach the right healthcare professionals (HCPs) ...

Despite being on the US market since 1989 – initially for medical uses like strabismus and blepharospasm, and later for ...

Penpulimab has picked up a pair of approvals in nasopharyngeal carcinoma (NPC), becoming only the second drug to be cleared ...

Lawyers for Todd Engel, 62, filed suit yesterday in New Jersey superior court. According to the complaint, Engel is now ...

The 6th Gene Therapy Analytical Development Summit Europe, taking place from 20 th – 22 nd May 2025 in London, returns as the ...

Northwestern University spinout Grove Biopharma, a synthetic biology specialist developing a platform known as Bionic ...

Health and Human Services (HHS) Secretary Robert F Kennedy Jr, who oversees the FDA, has made no secret of his desire to ban ...